Cytek Biosciences (CTKB) Current Deferred Revenue (2020 - 2026)
Cytek Biosciences (CTKB) reported Current Deferred Revenue of $29.21 million for Q2 2026, up 3.8% from $28.13 million a year earlier but down 2.8% from the prior quarter.
Cytek Biosciences (CTKB) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Cytek Biosciences posted Current Deferred Revenue of $28.5 million, up 11.8% from FY2024.
- Current Deferred Revenue has increased for five consecutive years, with a five-year compound annual growth rate of 50.7% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $25.49 million in FY2024 (+12.3%), $22.7 million in FY2023 (+74.8%), $12.99 million in FY2022 (+83.4%) and $7.08 million in FY2021 (+93.2%).
- Five-year quarterly Current Deferred Revenue spans a low of $5.89 million in Q3 2021 and a high of $30.03 million in Q1 2026.
- Year over year, Current Deferred Revenue has now increased in each of the last 17 quarters, with growth averaging 12.2% over the last eight quarters.
- The year-over-year growth in Current Deferred Revenue has ranged between 3.8% (Q2 2026) and 114.0% (Q2 2022) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $30.03 million (Q1 2026), $28.5 million (Q4 2025) and $28.74 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn |
| 10 | Cytek Biosciences | 774.70 Mn | 450.97 Mn | 28.34 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.21 Mn |
| Mar 31, 2026 | 30.03 Mn |
| Dec 31, 2025 | 28.50 Mn |
| Sep 30, 2025 | 28.74 Mn |
| Jun 30, 2025 | 28.13 Mn |
| Mar 31, 2025 | 27.71 Mn |
| Dec 31, 2024 | 25.49 Mn |
| Sep 30, 2024 | 25.37 Mn |
| Jun 30, 2024 | 23.97 Mn |
| Mar 31, 2024 | 23.01 Mn |
| Dec 31, 2023 | 22.70 Mn |
| Sep 30, 2023 | 23.05 Mn |
| Jun 30, 2023 | 20.61 Mn |
| Mar 31, 2023 | 18.10 Mn |
| Dec 31, 2022 | 12.99 Mn |
| Sep 30, 2022 | 12.09 Mn |
| Jun 30, 2022 | 9.99 Mn |
| Mar 31, 2022 | 12.25 Mn |
| Dec 31, 2021 | 7.08 Mn |
| Sep 30, 2021 | 5.89 Mn |
Cytek Biosciences Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CTKB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CTKB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CTKB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();